PIONEER

Clinical trial programme on which the authorisation of Rybelsus (oral semaglutide) at the original doses of 3, 7 and 14 mg was based; its efficacy and safety results are extrapolated to the new bioequivalent doses of 1.5, 4 and 9 mg.

Institutional endorsement by Clínica Evolution

Medical guides

Rybelsus or oral Wegovy for weight loss: which is authorised for weight management, how they differ and what they cost
Read →
Rybelsus 14 mg is now 9 mg: the new 1.5, 4 and 9 mg doses and their equivalents
Read →

Keep reading

Semaglutide Rybelsus Wegovy Oral semaglutide Ozempic Antidiabetic drugs Wegovy tablets Type 2 diabetes

This entry is for information. Your case requires an individual medical assessment.

PIONEER

Medical guides

Rybelsus or oral Wegovy for weight loss: which is authorised for weight management, how they differ and what they cost

Rybelsus 14 mg is now 9 mg: the new 1.5, 4 and 9 mg doses and their equivalents

Keep reading